19th Ave New York, NY 95822, USA

Home

MukoCell®  – Advanced therapy medicinal products –

The MukoCell® procedure is an approved and established procedure in Germany.

More information: https://www.pei.de/SharedDocs/arzneimittel/atmp/tep/PEI-A-11491-01-1.html

In Germany, more than 200 patients have already been treated with the MukoCell® procedure. The clinical data in a follow-up period of up to 36 months show that the procedure is safe and effective.

MukoCell GmbH is a biotechnology company, headquartered in Dortmund / Germany, which specializes in the production, development and distribution of laboratory-produced patient-derived tissue substitutes for organ reconstruction.

The tissue substitute (MukoCell®), which originates from the company’s own research and development, is the world’s first tissue product (ATMP) in urology manufactured from the patient’s own cells. The advanced therapy medicinal product MukoCell® is an oral mucosal graft grown from the patient’s own cells for the reconstruction of the urethra.

Harnröhrenstriktur: Harnröhrenrekonstruktion mit im Labor hergestelltem Gewebeersatz

MukoCell® ist eine schonende Alternative zur herkömmlichen Transplantation mit nativer Mundschleimhaut. Der aus patienteneigenen Zellen gezüchtete Gewebeersatz integriert sich innerhalb kurzer Zeit in das umgebende Gewebe und entwickelt sich zu neuem, voll funktionsfähigem Harnröhrengewebe. Mehr Information zum Thema Harnröhrenstriktur finden Sie auch auf Wikipedia.